Dimension Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
September 2018
41
About the Report
About the Report
Summary
Dimension Therapeutics Inc (Dimension Therapeutics) is a developer of therapeutic products for the treatment of rare diseases associated with liver and genetic mutations. The company develops its product pipeline based on its mammalian adeno-associated virus gene delivery technology. Its products under development are intended for the treatment of inherited metabolic diseases including ornithine transcarbamylase deficiency, glycogen storage disease type Ia (GSDIa), citrullinemia type 1, PKU, wilson disease and hemophilia. The company also develops and commercialize product candidates for the treatment of hemophilia A. Dimension Therapeutics is headquartered in Cambridge, Massachusetts, the US.
Dimension Therapeutics Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Dimension Therapeutics Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Dimension Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Dimension Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Dimension Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Dimension Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Dimension Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Dimension Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Dimension Therapeutics Raises USD65 Million in Series B Financing 11
Dimension Therapeutics Raises USD30 Million in Venture Financing 13
Dimension Therapeutics Raises USD5 Million in Series A Financing 14
Partnerships 15
Aptuit Enters into Agreement with Dimension Therapeutics 15
Dimension Therapeutics Enters into R&D Agreement with Eunice Kennedy Shriver National Institute 16
Dimension Therapeutics Amends Research Agreement with University of Pennsylvania 17
Licensing Agreements 18
Dimension Therapeutics Enters into Licensing Agreement with Perelman School of Medicine at the University of Pennsylvania 18
ReGenX Biosciences Enters into Option And Licensing Agreement with Dimension Therapeutics 19
Bayer HealthCare Enters into Licensing Agreement with Dimension Therapeutics for Hemophilia A 20
ReGenX Biosciences Amends Licensing Agreement With Dimension Therapeutics 21
Equity Offering 22
Dimension Therapeutics Plans to Raise up to USD35 Million in Public Offering of Shares 22
Dimension Therapeutics Prices IPO for USD72.86 Million 23
Acquisition 25
Ultragenyx Pharma Acquires Dimension Therapeutics for USD152.3 Million 25
RegenxBio to Acquire Dimension Therapeutics 27
Dimension Therapeutics Inc-Key Competitors 29
Dimension Therapeutics Inc-Key Employees 30
Dimension Therapeutics Inc-Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Recent Developments 32
Financial Announcements 32
Aug 08, 2017: Dimension Therapeutics Reports Second Quarter 2017 Financial Results and Provides Corporate Update 32
May 10, 2017: Dimension Therapeutics Reports First Quarter 2017 Financial Results and Provides Corporate Update 34
Mar 09, 2017: Dimension Therapeutics Announces Full Year 2016 Financial Results and Recent Updates Across Rare and Metabolic Disease Portfolio and in HeLa Manufacturing 36
Corporate Communications 38
Jul 24, 2017: Dimension Therapeutics Announces Management Change 38
Feb 07, 2017: Dimension Therapeutics Elects Dr. John A. Hohneker to Its Board of Directors 39
Other Significant Developments 40
Jun 27, 2017: Dimension Therapeutics Completes Strategic Review and Updates Corporate Priorities 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41
List of Figure
List of Figures
Dimension Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Dimension Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Dimension Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Dimension Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Dimension Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Dimension Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Dimension Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Dimension Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
List of Table
List of Tables
Dimension Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Dimension Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Dimension Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Dimension Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Dimension Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Dimension Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Dimension Therapeutics Raises USD65 Million in Series B Financing 11
Dimension Therapeutics Raises USD30 Million in Venture Financing 13
Dimension Therapeutics Raises USD5 Million in Series A Financing 14
Aptuit Enters into Agreement with Dimension Therapeutics 15
Dimension Therapeutics Enters into R&D Agreement with Eunice Kennedy Shriver National Institute 16
Dimension Therapeutics Amends Research Agreement with University of Pennsylvania 17
Dimension Therapeutics Enters into Licensing Agreement with Perelman School of Medicine at the University of Pennsylvania 18
ReGenX Biosciences Enters into Option And Licensing Agreement with Dimension Therapeutics 19
Bayer HealthCare Enters into Licensing Agreement with Dimension Therapeutics for Hemophilia A 20
ReGenX Biosciences Amends Licensing Agreement With Dimension Therapeutics 21
Dimension Therapeutics Plans to Raise up to USD35 Million in Public Offering of Shares 22
Dimension Therapeutics Prices IPO for USD72.86 Million 23
Ultragenyx Pharma Acquires Dimension Therapeutics for USD152.3 Million 25
RegenxBio to Acquire Dimension Therapeutics 27
Dimension Therapeutics Inc, Key Competitors 29
Dimension Therapeutics Inc, Key Employees 30
Dimension Therapeutics Inc, Subsidiaries 31
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.